as
measured by the HAM-D in comparison with those who received
saline solutions (Berman et al., 2000). As ketamine is a highaffinity NMDA receptor antagonist, these results suggest that the
glutamate system may play a critical role in the treatment of MDD
(Berman et al., 2000). In a novel study